BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 23060593)

  • 61. Analysis of potential genes and pathways associated with the colorectal normal mucosa-adenoma-carcinoma sequence.
    Wu Z; Liu Z; Ge W; Shou J; You L; Pan H; Han W
    Cancer Med; 2018 Jun; 7(6):2555-2566. PubMed ID: 29659199
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Elevated TIMP-1 expression is associated with a prometastatic phenotype, disease relapse, and poor survival in neuroblastoma.
    Paul P; Rellinger EJ; Qiao J; Lee S; Volny N; Padmanabhan C; Romain CV; Mobley B; Correa H; Chung DH
    Oncotarget; 2017 Oct; 8(47):82609-82620. PubMed ID: 29137288
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Identification of molecular characteristics induced by radiotherapy in rectal cancer based on microarray data.
    Ge C; Wu M; Chen G; Yu G; Ji D; Wang S
    Oncol Lett; 2017 Apr; 13(4):2777-2783. PubMed ID: 28454466
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Evaluation of hyaluronic acid, procollagen type III N-terminal peptide, and tissue inhibitor of matrix metalloproteinase-1 as serum markers of canine hepatic fibrosis.
    Lidbury JA; Hoffmann AR; Fry JK; Suchodolski JS; Steiner JM
    Can J Vet Res; 2016 Oct; 80(4):302-308. PubMed ID: 27733785
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Premetastatic niche formation in the liver: emerging mechanisms and mouse models.
    Krüger A
    J Mol Med (Berl); 2015 Nov; 93(11):1193-201. PubMed ID: 26400831
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The extracellular matrix: Tools and insights for the "omics" era.
    Naba A; Clauser KR; Ding H; Whittaker CA; Carr SA; Hynes RO
    Matrix Biol; 2016 Jan; 49():10-24. PubMed ID: 26163349
    [TBL] [Abstract][Full Text] [Related]  

  • 67. TIMP-1 signaling via CD63 triggers granulopoiesis and neutrophilia in mice.
    Kobuch J; Cui H; Grünwald B; Saftig P; Knolle PA; Krüger A
    Haematologica; 2015 Aug; 100(8):1005-13. PubMed ID: 26001794
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Circulating gelatinases and tissue inhibitor of metalloproteinase-1 in colorectal cancer metastatic liver disease.
    Waas ET; Wobbes T; Ruers T; Lomme RM; Hendriks T
    Eur J Surg Oncol; 2006 Sep; 32(7):756-63. PubMed ID: 16650961
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Prognostic significance of TIMP-1 in non-small cell lung cancer.
    Pesta M; Kulda V; Kucera R; Pesek M; Vrzalova J; Liska V; Pecen L; Treska V; Safranek J; Prazakova M; Vycital O; Bruha J; Holubec L; Topolcan O
    Anticancer Res; 2011 Nov; 31(11):4031-8. PubMed ID: 22110238
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Soluble CXCL16 in preoperative serum is a novel prognostic marker and predicts recurrence of liver metastases in colorectal cancer patients.
    Matsushita K; Toiyama Y; Tanaka K; Saigusa S; Hiro J; Uchida K; Inoue Y; Kusunoki M
    Ann Surg Oncol; 2012 Jul; 19 Suppl 3():S518-27. PubMed ID: 21845497
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Preoperative serum carcinoembryonic antigen level as a predictive factor of recurrence after curative resection of colorectal cancer.
    Takagawa R; Fujii S; Ohta M; Nagano Y; Kunisaki C; Yamagishi S; Osada S; Ichikawa Y; Shimada H
    Ann Surg Oncol; 2008 Dec; 15(12):3433-9. PubMed ID: 18846401
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Dynamics of serum levels of tumour markers and prognosis of recurrence and survival after liver surgery for colorectal liver metastases.
    Liska V; Holubec L; Treska V; Skalicky T; Sutnar A; Kormunda S; Pesta M; Finek J; Rousarova M; Topolcan O
    Anticancer Res; 2007; 27(4C):2861-4. PubMed ID: 17695461
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Plasma TIMP1 level is a prognostic factor in patients with liver metastases.
    Bunatova K; Pesta M; Kulda V; Topolcan O; Vrzalova J; Sutnar A; Treska V; Pecen L; Liska V
    Anticancer Res; 2012 Oct; 32(10):4601-6. PubMed ID: 23060593
    [TBL] [Abstract][Full Text] [Related]  

  • 74.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 75.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 76.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 77.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 78.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 79.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 4.